img

Global Next-Generation Oncology Solution Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Next-Generation Oncology Solution Market Research Report 2024

Next-generation oncology solutions refer to the advanced and innovative technologies, treatments, and approaches used to diagnose, treat, and manage cancer more effectively and efficiently. These solutions aim to improve patient outcomes, enhance precision medicine, and streamline oncology care by leveraging cutting-edge technologies and personalized treatment approaches.
According to MRAResearch’s new survey, global Next-Generation Oncology Solution market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Next-Generation Oncology Solution market research.
The global market for next-generation oncology solutions has been witnessing substantial growth and innovation, driven by advancements in genomics, precision medicine, immunotherapy, and data analytics. These cutting-edge solutions are transforming cancer care by providing more personalized and effective treatment options for patients. The rising incidence of cancer worldwide is propelling the demand for advanced oncology solutions that can offer better treatment outcomes and improved patient care. Precision medicine approaches, which use genomic testing and targeted therapies, have gained prominence, driving the adoption of next-gen oncology solutions. The United States, in particular, is a major market for next-gen oncology solutions due to its robust research and development infrastructure, extensive clinical trials, and high cancer incidence. European countries have been early adopters of precision medicine and advanced oncology treatments, contributing to the growth of the market in this region. The Asia-Pacific region is witnessing significant growth in the oncology market, with countries like China, India, and Japan investing in healthcare infrastructure and research. The global market for next-generation oncology solutions is expected to continue its growth trajectory in the coming years. As technology continues to advance, precision medicine becomes more personalized, and immunotherapy gains further momentum, next-gen oncology solutions are likely to play an increasingly significant role in cancer care. Moreover, collaborations between pharmaceutical companies, research institutions, and healthcare providers are likely to drive innovation and accelerate the development and adoption of next-gen oncology treatments worldwide.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Next-Generation Oncology Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Illumina
PerkinElmer
Thermo Fisher Scientific
Roche Holding
Agilent Technologies
Paige
GE Healthcare
Varian
Brainlab
Qiagen
Hologic
Pacific Biosciences
AstraZeneca
BGI Group
Segment by Type
Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
Software
Others

Segment by Application


Hospitals
Diagnostic Imaging Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Next-Generation Oncology Solution report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next-Generation Oncology Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
1.2.3 Software
1.2.4 Others
1.3 Market by Application
1.3.1 Global Next-Generation Oncology Solution Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Diagnostic Imaging Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next-Generation Oncology Solution Market Perspective (2018-2033)
2.2 Next-Generation Oncology Solution Growth Trends by Region
2.2.1 Global Next-Generation Oncology Solution Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Next-Generation Oncology Solution Historic Market Size by Region (2018-2023)
2.2.3 Next-Generation Oncology Solution Forecasted Market Size by Region (2024-2033)
2.3 Next-Generation Oncology Solution Market Dynamics
2.3.1 Next-Generation Oncology Solution Industry Trends
2.3.2 Next-Generation Oncology Solution Market Drivers
2.3.3 Next-Generation Oncology Solution Market Challenges
2.3.4 Next-Generation Oncology Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next-Generation Oncology Solution Players by Revenue
3.1.1 Global Top Next-Generation Oncology Solution Players by Revenue (2018-2023)
3.1.2 Global Next-Generation Oncology Solution Revenue Market Share by Players (2018-2023)
3.2 Global Next-Generation Oncology Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next-Generation Oncology Solution Revenue
3.4 Global Next-Generation Oncology Solution Market Concentration Ratio
3.4.1 Global Next-Generation Oncology Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Oncology Solution Revenue in 2022
3.5 Next-Generation Oncology Solution Key Players Head office and Area Served
3.6 Key Players Next-Generation Oncology Solution Product Solution and Service
3.7 Date of Enter into Next-Generation Oncology Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next-Generation Oncology Solution Breakdown Data by Type
4.1 Global Next-Generation Oncology Solution Historic Market Size by Type (2018-2023)
4.2 Global Next-Generation Oncology Solution Forecasted Market Size by Type (2024-2033)
5 Next-Generation Oncology Solution Breakdown Data by Application
5.1 Global Next-Generation Oncology Solution Historic Market Size by Application (2018-2023)
5.2 Global Next-Generation Oncology Solution Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Next-Generation Oncology Solution Market Size (2018-2033)
6.2 North America Next-Generation Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Next-Generation Oncology Solution Market Size by Country (2018-2023)
6.4 North America Next-Generation Oncology Solution Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next-Generation Oncology Solution Market Size (2018-2033)
7.2 Europe Next-Generation Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Next-Generation Oncology Solution Market Size by Country (2018-2023)
7.4 Europe Next-Generation Oncology Solution Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next-Generation Oncology Solution Market Size (2018-2033)
8.2 Asia-Pacific Next-Generation Oncology Solution Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Next-Generation Oncology Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific Next-Generation Oncology Solution Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next-Generation Oncology Solution Market Size (2018-2033)
9.2 Latin America Next-Generation Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Next-Generation Oncology Solution Market Size by Country (2018-2023)
9.4 Latin America Next-Generation Oncology Solution Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next-Generation Oncology Solution Market Size (2018-2033)
10.2 Middle East & Africa Next-Generation Oncology Solution Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Next-Generation Oncology Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa Next-Generation Oncology Solution Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Next-Generation Oncology Solution Introduction
11.1.4 Illumina Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Detail
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Next-Generation Oncology Solution Introduction
11.2.4 PerkinElmer Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.2.5 PerkinElmer Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Next-Generation Oncology Solution Introduction
11.3.4 Thermo Fisher Scientific Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Roche Holding
11.4.1 Roche Holding Company Detail
11.4.2 Roche Holding Business Overview
11.4.3 Roche Holding Next-Generation Oncology Solution Introduction
11.4.4 Roche Holding Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.4.5 Roche Holding Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Next-Generation Oncology Solution Introduction
11.5.4 Agilent Technologies Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.5.5 Agilent Technologies Recent Development
11.6 Paige
11.6.1 Paige Company Detail
11.6.2 Paige Business Overview
11.6.3 Paige Next-Generation Oncology Solution Introduction
11.6.4 Paige Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.6.5 Paige Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Detail
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Next-Generation Oncology Solution Introduction
11.7.4 GE Healthcare Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.7.5 GE Healthcare Recent Development
11.8 Varian
11.8.1 Varian Company Detail
11.8.2 Varian Business Overview
11.8.3 Varian Next-Generation Oncology Solution Introduction
11.8.4 Varian Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.8.5 Varian Recent Development
11.9 Brainlab
11.9.1 Brainlab Company Detail
11.9.2 Brainlab Business Overview
11.9.3 Brainlab Next-Generation Oncology Solution Introduction
11.9.4 Brainlab Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.9.5 Brainlab Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Next-Generation Oncology Solution Introduction
11.10.4 Qiagen Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.10.5 Qiagen Recent Development
11.11 Hologic
11.11.1 Hologic Company Detail
11.11.2 Hologic Business Overview
11.11.3 Hologic Next-Generation Oncology Solution Introduction
11.11.4 Hologic Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.11.5 Hologic Recent Development
11.12 Pacific Biosciences
11.12.1 Pacific Biosciences Company Detail
11.12.2 Pacific Biosciences Business Overview
11.12.3 Pacific Biosciences Next-Generation Oncology Solution Introduction
11.12.4 Pacific Biosciences Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.12.5 Pacific Biosciences Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Detail
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Next-Generation Oncology Solution Introduction
11.13.4 AstraZeneca Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.13.5 AstraZeneca Recent Development
11.14 BGI Group
11.14.1 BGI Group Company Detail
11.14.2 BGI Group Business Overview
11.14.3 BGI Group Next-Generation Oncology Solution Introduction
11.14.4 BGI Group Revenue in Next-Generation Oncology Solution Business (2018-2023)
11.14.5 BGI Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Next-Generation Oncology Solution Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)
Table 3. Key Players of Software
Table 4. Key Players of Others
Table 5. Global Next-Generation Oncology Solution Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Next-Generation Oncology Solution Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Next-Generation Oncology Solution Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Next-Generation Oncology Solution Market Share by Region (2018-2023)
Table 9. Global Next-Generation Oncology Solution Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Next-Generation Oncology Solution Market Share by Region (2024-2033)
Table 11. Next-Generation Oncology Solution Market Trends
Table 12. Next-Generation Oncology Solution Market Drivers
Table 13. Next-Generation Oncology Solution Market Challenges
Table 14. Next-Generation Oncology Solution Market Restraints
Table 15. Global Next-Generation Oncology Solution Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Next-Generation Oncology Solution Market Share by Players (2018-2023)
Table 17. Global Top Next-Generation Oncology Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Oncology Solution as of 2022)
Table 18. Ranking of Global Top Next-Generation Oncology Solution Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Next-Generation Oncology Solution Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Next-Generation Oncology Solution Product Solution and Service
Table 22. Date of Enter into Next-Generation Oncology Solution Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Next-Generation Oncology Solution Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Next-Generation Oncology Solution Revenue Market Share by Type (2018-2023)
Table 26. Global Next-Generation Oncology Solution Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Next-Generation Oncology Solution Revenue Market Share by Type (2024-2033)
Table 28. Global Next-Generation Oncology Solution Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Next-Generation Oncology Solution Revenue Market Share by Application (2018-2023)
Table 30. Global Next-Generation Oncology Solution Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Next-Generation Oncology Solution Revenue Market Share by Application (2024-2033)
Table 32. North America Next-Generation Oncology Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Next-Generation Oncology Solution Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Next-Generation Oncology Solution Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Next-Generation Oncology Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Next-Generation Oncology Solution Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Next-Generation Oncology Solution Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Next-Generation Oncology Solution Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Next-Generation Oncology Solution Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Next-Generation Oncology Solution Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Next-Generation Oncology Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Next-Generation Oncology Solution Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Next-Generation Oncology Solution Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Next-Generation Oncology Solution Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Next-Generation Oncology Solution Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Next-Generation Oncology Solution Market Size by Country (2024-2033) & (US$ Million)
Table 47. Illumina Company Detail
Table 48. Illumina Business Overview
Table 49. Illumina Next-Generation Oncology Solution Product
Table 50. Illumina Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 51. Illumina Recent Development
Table 52. PerkinElmer Company Detail
Table 53. PerkinElmer Business Overview
Table 54. PerkinElmer Next-Generation Oncology Solution Product
Table 55. PerkinElmer Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 56. PerkinElmer Recent Development
Table 57. Thermo Fisher Scientific Company Detail
Table 58. Thermo Fisher Scientific Business Overview
Table 59. Thermo Fisher Scientific Next-Generation Oncology Solution Product
Table 60. Thermo Fisher Scientific Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 61. Thermo Fisher Scientific Recent Development
Table 62. Roche Holding Company Detail
Table 63. Roche Holding Business Overview
Table 64. Roche Holding Next-Generation Oncology Solution Product
Table 65. Roche Holding Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 66. Roche Holding Recent Development
Table 67. Agilent Technologies Company Detail
Table 68. Agilent Technologies Business Overview
Table 69. Agilent Technologies Next-Generation Oncology Solution Product
Table 70. Agilent Technologies Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 71. Agilent Technologies Recent Development
Table 72. Paige Company Detail
Table 73. Paige Business Overview
Table 74. Paige Next-Generation Oncology Solution Product
Table 75. Paige Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 76. Paige Recent Development
Table 77. GE Healthcare Company Detail
Table 78. GE Healthcare Business Overview
Table 79. GE Healthcare Next-Generation Oncology Solution Product
Table 80. GE Healthcare Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 81. GE Healthcare Recent Development
Table 82. Varian Company Detail
Table 83. Varian Business Overview
Table 84. Varian Next-Generation Oncology Solution Product
Table 85. Varian Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 86. Varian Recent Development
Table 87. Brainlab Company Detail
Table 88. Brainlab Business Overview
Table 89. Brainlab Next-Generation Oncology Solution Product
Table 90. Brainlab Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 91. Brainlab Recent Development
Table 92. Qiagen Company Detail
Table 93. Qiagen Business Overview
Table 94. Qiagen Next-Generation Oncology Solution Product
Table 95. Qiagen Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 96. Qiagen Recent Development
Table 97. Hologic Company Detail
Table 98. Hologic Business Overview
Table 99. Hologic Next-Generation Oncology Solution Product
Table 100. Hologic Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 101. Hologic Recent Development
Table 102. Pacific Biosciences Company Detail
Table 103. Pacific Biosciences Business Overview
Table 104. Pacific Biosciences Next-Generation Oncology Solution Product
Table 105. Pacific Biosciences Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 106. Pacific Biosciences Recent Development
Table 107. AstraZeneca Company Detail
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Next-Generation Oncology Solution Product
Table 110. AstraZeneca Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 111. AstraZeneca Recent Development
Table 112. BGI Group Company Detail
Table 113. BGI Group Business Overview
Table 114. BGI Group Next-Generation Oncology Solution Product
Table 115. BGI Group Revenue in Next-Generation Oncology Solution Business (2018-2023) & (US$ Million)
Table 116. BGI Group Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next-Generation Oncology Solution Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Next-Generation Oncology Solution Market Share by Type: 2022 VS 2033
Figure 3. Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy) Features
Figure 4. Software Features
Figure 5. Others Features
Figure 6. Global Next-Generation Oncology Solution Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Next-Generation Oncology Solution Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Diagnostic Imaging Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Next-Generation Oncology Solution Report Years Considered
Figure 12. Global Next-Generation Oncology Solution Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Next-Generation Oncology Solution Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Next-Generation Oncology Solution Market Share by Region: 2022 VS 2033
Figure 15. Global Next-Generation Oncology Solution Market Share by Players in 2022
Figure 16. Global Top Next-Generation Oncology Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Oncology Solution as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Next-Generation Oncology Solution Revenue in 2022
Figure 18. North America Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Next-Generation Oncology Solution Market Share by Country (2018-2033)
Figure 20. United States Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Next-Generation Oncology Solution Market Share by Country (2018-2033)
Figure 24. Germany Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Next-Generation Oncology Solution Market Share by Region (2018-2033)
Figure 32. China Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Next-Generation Oncology Solution Market Share by Country (2018-2033)
Figure 40. Mexico Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Next-Generation Oncology Solution Market Share by Country (2018-2033)
Figure 44. Turkey Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Next-Generation Oncology Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Illumina Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 47. PerkinElmer Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 49. Roche Holding Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 50. Agilent Technologies Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 51. Paige Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 52. GE Healthcare Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 53. Varian Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 54. Brainlab Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 55. Qiagen Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 56. Hologic Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 57. Pacific Biosciences Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 58. AstraZeneca Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 59. BGI Group Revenue Growth Rate in Next-Generation Oncology Solution Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries